New research carried out in collaboration with the University of Birmingham has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots.
Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
Dr Julie Rayes was awarded a reputable Fellowship to study, test and repurpose drugs to limit thrombo-inflammation caused by infection or congenital disorders.
A new EU-funded collaborative research project will develop the first integrative digital platform for diagnosing atrial cardiomyopathy.
Experts have come together to discuss the latest innovations in atrial fibrillation research and publish a set of agreed clinical and research recommendations.
Article about Professor Dipak Kotecha, Associate Editor of Karger and Professor of Cardiology at the Institute of Cardiovascular Sciences, where he talks about himself and his research.
A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when treating patients with permanent atrial fibrillation.
Dr Christopher O'Shea from at the Institute of Cardiovascular Sciences has been awarded a prestigious Postdoctoral Fellowship from the Wellcome Trust.
Mr Nigel Drury, Clinician Scientist in Paediatric Cardiac Surgery at the University of Birmingham, has received the prestigious Hunterian Professorship.
Dr James Guggenheim has been appointed as a Birmingham Fellow with the Institute of Cardiovascular Sciences at the University of Birmingham.